ANALYSIS: Biotech & Pharma Buyers to Spend More on Tech in 2026

Nov. 12, 2025, 2:00 AM UTC

The M&A market experienced an incredible third quarter this year, and deal volumes reached totals not seen since 2021. The biotechnology and pharmaceuticals industry and the medical equipment and devices industry also had a robust Q3, as deals involving at least one party in these industries totaled $87.83 billion, which was the highest deal volume since Q4 2021 ($103.79 billion).

Next year, the M&A market has the potential to break the records set in 2021, and the biotech and pharma as well as the medical equipment and devices industries also have the potential to surpass their 2021 deal volumes. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.